Deregulated DNA polymerase β induces chromosome instability and tumorigenesis

To reach the biological alterations that characterize cancer, the genome of tumor cells must acquire increased mutability resulting from a malfunction of a network of genome stability systems, e.g., cell cycle arrest, DNA repair, and high accuracy of DNA synthesis during DNA replication. Numeric chromosomal imbalance, referred to as aneuploidy, is the most prevalent genetic changes recorded among many types of solid tumors. We report here that ectopic expression in cells of DNA polymerase β, an error-prone enzyme frequently over-regulated in human tumors, induces aneuploidy, an abnormal localization of the centrosome-associated γ-tubulin protein during mitosis, a deficient mitotic checkpoint, and promotes tumorigenesis in nude immunodeficient mice. Thus, we find that alteration of polymerase β expression appears to induce major genetic changes associated with a malignant phenotype.

[1]  H. Hayakawa,et al.  Involvement of DNA polymerase β in DNA replication and mutagenic consequences , 2002 .

[2]  R. Goldsby,et al.  Defective DNA polymerase-δ proofreading causes cancer susceptibility in mice , 2001, Nature Medicine.

[3]  L. Liotta,et al.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.

[4]  R. Benezra,et al.  Mitotic checkpoints: from yeast to cancer. , 2001, Current opinion in genetics & development.

[5]  C. Wilson,et al.  Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation , 2000, Nature Cell Biology.

[6]  H. Hayakawa,et al.  Nucleotide excision repair DNA synthesis by excess DNA polymerase β: a potential source of genetic instability in cancer cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  K. Loeb,et al.  Significance of multiple mutations in cancer. , 2000, Carcinogenesis.

[8]  W. Lingle,et al.  Altered centrosome structure is associated with abnormal mitoses in human breast tumors. , 1999, The American journal of pathology.

[9]  A. Ashworth,et al.  Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification , 1999, Current Biology.

[10]  Y. Canitrot,et al.  Overexpression of DNA polymerase β: a genomic instability enhancer process , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Samuel H. Wilson,et al.  DNA polymerase β expression differences in selected human tumors and cell lines , 1999 .

[12]  M. Aardema,et al.  Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. , 1999, Mutation research.

[13]  X. Wang,et al.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. , 1999, Molecular cell.

[14]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[15]  Y. Canitrot,et al.  Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H Knecht,et al.  Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.

[17]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[18]  Samuel H. Wilson,et al.  Requirement of mammalian DNA polymerase-β in base-excision repair , 1996, Nature.

[19]  A. Debec,et al.  Recruitment of antigenic gamma-tubulin during mitosis in animal cells: presence of gamma-tubulin in the mitotic spindle. , 1994, Journal of cell science.

[20]  H. Joshi Microtubule organizing centers and γ-tubulin , 1994 .

[21]  H. Mazarguil,et al.  gamma-Tubulin participates in the formation of the midbody during cytokinesis in mammalian cells. , 1993, Journal of cell science.

[22]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[23]  C. Cazaux,et al.  Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine. , 1997, Cancer research.

[24]  M. Kashani-Sabet,et al.  Differential gene expression in human cancer cells resistant to cisplatin. , 1989, Cancer investigation.